clavulanic acid has been researched along with Cronobacter Infections in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evenhuis, J; Griffin, M; Harbottle, H; McDermott, PF; Miller, RA; Welch, TJ; White, DG; Wise, D | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
| Ansari, M; Munir, T; Saad, N | 1 |
| Bakthavatchalu, S; Mishra, T; Shakthivel, U | 1 |
| Aubert, V; Baserni, MN; Jugo, MB; Villar, HE | 1 |
| González-López, JJ; Martínez-Martínez, L | 1 |
| Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M | 1 |
| Jeong, SH; Kim, HS; Kim, JS; Lee, KM; Song, W | 1 |
| Herrera, M; Jorgensen, JH; Lewis, JS; Towne, TG; Wickes, B | 1 |
| Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
| Costa, N; Couto, E; Gardella, N; Gutkind, G; Korbenfeld, D; Quinteros, M; Radice, M; Rodriguez, MM | 1 |
| Bell, JM; Jones, RN; Turnidge, JD | 1 |
| Laufs, R; Mack, D; Noor, D; Sobottka, I; Stürenburg, E | 1 |
| Ben Meriem, C; Ghedira Besbes, L; Guediche, MN; Messaoudi, A | 1 |
| Chen, HE; Cheng, KC; Chi, CJ; Chuang, YC; Wu, LT; Yu, WL | 1 |
| Ge, Y; Kaniga, K; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| Hope, R; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| Ball, AP; Brookes, GR; Davey, PG; Farrell, ID; Geddes, AM | 1 |
| Levenstein, JH | 1 |
| Kim, KH; Park, KW; Yim, CB | 1 |
| Corkill, JE; Parry, C; Percival, A | 1 |
| Haboubi, NY; Lee, GS; Montgomery, RD | 1 |
| Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J | 1 |
| Aronoff, SC; Jacobs, MR; Labrozzi, PH; Yamabe, S | 1 |
| Aubert, G; Denis, M; Dorche, G; Lallard, P | 1 |
2 review(s) available for clavulanic acid and Cronobacter Infections
| Article | Year |
|---|---|
Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Global Health; Humans; Plasmids; Substrate Specificity; Zinc | 2014 |
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2008 |
2 trial(s) available for clavulanic acid and Cronobacter Infections
| Article | Year |
|---|---|
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
Topics: Administration, Oral; Amoxicillin; Bacteriuria; beta-Lactamase Inhibitors; beta-Lactams; Biological Products; Carboxylic Acids; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptomyces; Tablets; Urinary Tract Infections | 1980 |
Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Child; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae Infections; Family Practice; Female; Humans; Lactams; Male; Middle Aged; Skin Diseases, Infectious; Staphylococcal Infections; Urinary Tract Infections | 1982 |
21 other study(ies) available for clavulanic acid and Cronobacter Infections
| Article | Year |
|---|---|
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
Topics: Animals; Anti-Bacterial Agents; Catfishes; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Edwardsiella ictaluri; Enterobacteriaceae Infections; Fish Diseases; Molecular Sequence Data; Plasmids; Thiamphenicol | 2009 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2018 |
Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Body Fluids; Boronic Acids; Cefepime; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Substrate Specificity | 2013 |
Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Gestational Age; Humans; Maternal Exposure; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vagina | 2013 |
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult | 2017 |
Broth microdilution method to detect extended-spectrum beta-lactamases and AmpC beta-lactamases in enterobacteriaceae isolates by use of clavulanic acid and boronic acid as inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Clavulanic Acid; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2009 |
Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2010 |
Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2009 |
Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.
Topics: Argentina; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Hospitals, Public; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.
Topics: Asia; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Pacific Islands; Penicillins; Phenotype; South Africa | 2003 |
Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Phenotype | 2004 |
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Topics: Adolescent; Age Factors; Aminoglycosides; Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporin Resistance; Cephalosporins; Cephalothin; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Male; Penicillin Resistance; Proteus mirabilis; Retrospective Studies; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli Proteins; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Taiwan | 2006 |
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; beta-Lactamases; Ceftaroline; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Escherichia coli; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Diseases; Staphylococcus | 2007 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
Enterobacter cloacae with clavulanic acid dependent variants.
Topics: Aged; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Microbial Sensitivity Tests | 1991 |
Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clavulanic Acid; Clavulanic Acids; Duodenitis; Enterobacteriaceae; Enterobacteriaceae Infections; Erythromycin; Female; Humans; Image Processing, Computer-Assisted; Intestinal Mucosa; Male; Microscopy; Tetracycline | 1991 |
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Fleroxacin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.
Topics: Amoxicillin; Animals; Bacterial Infections; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Mice; Penicillanic Acid; Proteus Infections; Staphylococcal Infections; Tazobactam | 1986 |
[Comparative study of a combination of amoxicillin and clavulanic acid and a combination of ticarcillin and clavulanic acid on 249 enterobacteria].
Topics: Amoxicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; In Vitro Techniques; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1988 |